MEDBOT-B (02252) has announced that the company received approval from the Hong Kong Stock Exchange dated February 13, 2026, for the listing and trading of 5.9898 million H shares (converted H shares), which is the total number of non-listed shares to be converted and listed. The conversion and listing will involve a total of 5.9898 million non-listed shares held by two of the company's shareholders (participating shareholders), accounting for approximately 0.5808% of the company's total issued shares as of the date of this announcement.